Banking software provider Zeta netted $30m from investors including Mastercard at a $1.5bn valuation while drug development services provider Staq Pharma closed its series C round.


US-headquartered banking software provider Zeta has received $30m in funding from investors including payment services firm Mastercard at a $1.5bn valuation, it disclosed today. The capital will be added to the $240m the company raised from investors including telecoms and internet group SoftBank’s Vision Fund 2 in May 2021, and Zeta founder and CEO Bhavin Turakhia told VCCircle the $30m was secured the same month.

Staq Pharma, the US-based operator of a medication development outsourcing facility, has completed…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.